Cargando…

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

INTRODUCTION: Prenylated Rab acceptor 1 domain family member 2 (PRAF2), a novel oncogene, has been shown to be essential for the development of several human cancers; however, its role in hepatocellular carcinoma (HCC) remains unclear. MATERIALS AND METHODS: PRAF2 mRNA and protein expressions were e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chun-Hua, Liu, Li-Li, Liao, Ding-Zhun, Zhang, Mei-Fang, Fu, Jia, Lu, Shi-Xun, Chen, Shi-Lu, Wang, Hong, Cai, Shao-Hang, Zhang, Chris Zhiyi, Zhang, Hui-Zhong, Yun, Jing-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065608/ https://www.ncbi.nlm.nih.gov/pubmed/30100755 http://dx.doi.org/10.2147/CMAR.S166789

Ejemplares similares

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma
por: Cai, Shao-hang, et al.
Publicado: (2017)

Rab1a rescues the toxicity of PRAF3
por: Oshikane, Hiroyuki, et al.
Publicado: (2018)

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma
por: Xiao, Yong-bo, et al.
Publicado: (2018)

Connected function of PRAF/RLD and GNOM in membrane trafficking controls intrinsic cell polarity in plants
por: Wang, Lu, et al.
Publicado: (2022)

HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
por: Chen, Shi‐Lu, et al.
Publicado: (2017)

PRAF2 is an oncogene acting to promote the proliferation and invasion of breast cancer cells
por: Wang, Yabing, et al.
Publicado: (2022)

Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis
por: Yu, Tao, et al.
Publicado: (2020)

PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma
por: Shi, Guo-Zhen, et al.
Publicado: (2012)

Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
por: Zhang, Chris Zhiyi, et al.
Publicado: (2012)

PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma
por: Qian, Zhaoye, et al.
Publicado: (2019)

Mutual regulation of JAG2 and PRAF2 promotes migration and invasion of colorectal cancer cells uncoupled from epithelial–mesenchymal transition
por: He, Wan, et al.
Publicado: (2019)

Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes
por: Lu, Jia-bin, et al.
Publicado: (2018)

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Shi-Lu, et al.
Publicado: (2017)

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways
por: Chen, Shi‐Lu, et al.
Publicado: (2019)

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study
por: Lu, Shi-Xun, et al.
Publicado: (2021)

Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer
por: Xia, Bingshu, et al.
Publicado: (2016)

High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2017)

SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways
por: Li, Chunliu, et al.
Publicado: (2020)

High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma
por: Yang, Liting, et al.
Publicado: (2017)

Praf2 Is a Novel Bcl-xL/Bcl-2 Interacting Protein with the Ability to Modulate Survival of Cancer Cells
por: Vento, Maria Teresa, et al.
Publicado: (2010)

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer
por: Zhou, Wenbin, et al.
Publicado: (2018)

High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia
por: Yang, Xinrui, et al.
Publicado: (2019)

High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer
por: Chen, Zhitao, et al.
Publicado: (2021)

Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
por: Tang, Qin, et al.
Publicado: (2022)

Long non-coding RNA HOTAIR functions as a competitive endogenous RNA to regulate PRAF2 expression by sponging miR-326 in cutaneous squamous cell carcinoma
por: Yu, Guo-Jun, et al.
Publicado: (2019)

Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
por: Wang, He, et al.
Publicado: (2021)

Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer
por: Shen, Yanwei, et al.
Publicado: (2017)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
por: Gu, Xuefeng, et al.
Publicado: (2014)

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2
por: Liu, Li-Li, et al.
Publicado: (2014)

Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
por: Ji, Zaixiong, et al.
Publicado: (2021)

High-level SETD1B gene expression is associated with unfavorable prognosis in hepatocellular carcinoma
por: Chen, Dong, et al.
Publicado: (2019)

High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Li, Qiang, et al.
Publicado: (2021)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_su2nvgd1pr7aqrsau31p0kl0j4